Skip to main content

Bulk pharmaceutical and biopharmaceutical plant design considerations

  • Chapter
  • 1570 Accesses

Abstract

When designing and building a bulk pharamaceutical plant, there are many things to be considered that are different from biopharmaceutical or finished pharmaceutical facilities. In this chapter, we shall review some of the design parameters and considerations and shall contrast biopharmaceutical with bulk pharmaceutical plants.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Chapman & Hall

About this chapter

Cite this chapter

Lesnik, R. (1997). Bulk pharmaceutical and biopharmaceutical plant design considerations. In: Goldberg, E. (eds) Handbook of Downstream Processing. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1563-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1563-3_23

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7198-7

  • Online ISBN: 978-94-009-1563-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics